Literature DB >> 22872217

Antifibrinolytic agents reduce blood loss during pediatric vertebral column resection procedures.

Peter O Newton1, Tracey P Bastrom, John B Emans, Suken A Shah, Harry L Shufflebarger, Paul D Sponseller, Daniel J Sucato, Lawrence G Lenke.   

Abstract

STUDY
DESIGN: Retrospective multicenter review.
OBJECTIVE: To evaluate the effect of intraoperative antifibrinolytic (AF) agents on blood loss associated with vertebral column resection (VCR) procedures for pediatric patients. SUMMARY OF BACKGROUND DATA: VCR procedures may be associated with substantial blood loss.
METHODS: A multicenter review of 147 patients (aged <21 yr) who underwent VCR as part of their spinal deformity correction was conducted. Estimated blood loss (EBL) was calculated as percentage of blood volume (BV) (EBL/BV × 100), which was normalized on the basis of the number of vertebral levels removed (%BV/level). The use of AF agents was noted (tranexamic acid [TXA], aminocaproic acid, aprotinin, none) and based on surgeons' choice. EBL was compared using analysis of covariance (controlling for deformity magnitude) (P < 0.05).
RESULTS: Average preoperative major deformity (kyphosis or scoliosis) was 97° ± 31°. The average number of levels excised was 1.6 (range, 1-5). Total EBL averaged 1317 mL (range, 50-6026 mL). Eleven patients were excluded: 7 with incomplete data and 4 who received aminocaproic acid (too few to compare). This resulted in 136 cases; 64 with no AF, 42 received TXA, and 30 received aprotinin. Overall %BV/level EBL was 41% ± 39% (range, 6%-162%) and was significantly higher in the no-AF group (52% ± 37%) than the TXA (30% ± 34%; P < 0.01) and aprotinin (32% ± 24%; P < 0.05) groups. The effect of the AFs varied by site.
CONCLUSION: EBL associated with VCR was highly variable and in many cases exceeded the patient's BV. AF agents were not routinely used and we had insufficient data to assess the efficacy of aminocaproic acid. Both aprotinin and TXA resulted in less EBL than when no AF was used; however, the effect of the reduction varied by site. Aprotinin has since been removed from the market. When normalized to patient size and levels excised, the use of TXA resulted in a reduction in intraoperative EBL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22872217     DOI: 10.1097/BRS.0b013e31826c9fe4

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  10 in total

1.  Posterior Double Vertebral Column Resections Combined with Satellite Rod Technique to Correct Severe Congenital Angular Kyphosis.

Authors:  Xu Sun; Ze-Zhang Zhu; Xi Chen; Zhen Liu; Bin Wang; Yong Qiu
Journal:  Orthop Surg       Date:  2016-08       Impact factor: 2.071

2.  A Comparison of Two Different Dosing Protocols for Tranexamic Acid in Posterior Spinal Fusion for Spinal Deformity: A Prospective, Randomized Trial.

Authors:  Kushagra Verma; Eitan Kohan; Christopher P Ames; Dana L Cruz; Vedat Deviren; Sigurd Berven; Thomas J Errico
Journal:  Int J Spine Surg       Date:  2015-11-19

Review 3.  The use of tranexamic acid in spine surgery.

Authors:  Joon S Yoo; Junyoung Ahn; Sailee S Karmarkar; Eric H Lamoutte; Kern Singh
Journal:  Ann Transl Med       Date:  2019-09

Review 4.  Vertebral Column Resection for Rigid Spinal Deformity.

Authors:  Comron Saifi; Joseph L Laratta; Petros Petridis; Jamal N Shillingford; Ronald A Lehman; Lawrence G Lenke
Journal:  Global Spine J       Date:  2017-04-07

5.  Tranexamic Acid and Intraoperative and Postoperative Accumulative Bleeding in Elective Degenerative Spine Surgery.

Authors:  Mahmoud Abdou; Ji-Won Kwon; Hye Jin Kim; Bora Lee; Yong Seon Choi; Seong-Hwan Moon; Byung Ho Lee
Journal:  Yonsei Med J       Date:  2022-10       Impact factor: 3.052

6.  [Progress on the application of tranexamic acid in adolescent spine corrective surgery].

Authors:  Zhuang Zhang; Xi Yang; Lei Wang; Yueming Song
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-11-15

Review 7.  Systematic review and meta-analysis of perioperative intravenous tranexamic acid use in spinal surgery.

Authors:  Baohui Yang; Haopeng Li; Dong Wang; Xijing He; Chun Zhang; Pinglin Yang
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

8.  Effectiveness of tranexamic acid in reducing blood loss in spinal surgery: a meta-analysis.

Authors:  Fan Zhang; Kun Wang; Feng-Ning Li; Xuan Huang; Quan Li; Zhi Chen; Yi-Bo Tang; Hong-Xing Shen; Qing-Xin Song
Journal:  BMC Musculoskelet Disord       Date:  2014-12-22       Impact factor: 2.362

9.  Use of Tranexamic Acid (TXA) on reducing blood loss during scoliosis surgery in Chinese adolescents.

Authors:  Bobby K W Ng; W W Chau; Alec L H Hung; Anna Cn Hui; Tze Ping Lam; Jack C Y Cheng
Journal:  Scoliosis       Date:  2015-10-05

Review 10.  Efficacy and Safety of Antifibrinolytic Agents in Reducing Perioperative Blood Loss and Transfusion Requirements in Scoliosis Surgery: A Systematic Review and Meta-Analysis.

Authors:  Meng Wang; Xin-Feng Zheng; Lei-Sheng Jiang
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.